Spine BioPharma

Funding and NIH signals

• SEC Form D raise Raised $385K (Form D filed Jun 5, 2026). SEC Form D 0001852647-26-000002 (Jun 5, 2026)
  Evidence (1 event)

  • Jun 5, 2026 · SEC Form D 0001852647-26-000002
    Name of Issuer: Spine BioPharma, Inc.; CIK: 1852647; Address: New York, NY; Submission type: D; Filing date: 2026-06-05; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 8500000; Total Amount Sold: 384798; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals